Campagno K, Sripinun P, See L, Li J, Lu W, Jassim A
Int J Mol Sci. 2024; 25(16).
PMID: 39201471
PMC: 11354399.
DOI: 10.3390/ijms25168784.
Nunez-Rios J, Reyna-Jeldes M, Mata-Martinez E, Campos-Contreras A, Lazcano-Sanchez I, Gonzalez-Gallardo A
PLoS One. 2024; 19(6):e0304062.
PMID: 38870128
PMC: 11175443.
DOI: 10.1371/journal.pone.0304062.
Smolinska V, Harsanyi S, Bohac M, Danisovic L
Biomedicines. 2024; 12(1).
PMID: 38255159
PMC: 10813175.
DOI: 10.3390/biomedicines12010052.
Adinolfi E, De Marchi E, Grignolo M, Szymczak B, Pegoraro A
Int J Mol Sci. 2023; 24(18).
PMID: 37762206
PMC: 10531279.
DOI: 10.3390/ijms241813906.
Kaur J, Dora S
Front Oncol. 2023; 13:1058371.
PMID: 36741002
PMC: 9889871.
DOI: 10.3389/fonc.2023.1058371.
P2X7 receptor activation impairs antitumour activity of natural killer cells.
Baroja-Mazo A, Penin-Franch A, Lucas-Ruiz F, Torre-Minguela C, Alarcon-Vila C, Hernandez-Caselles T
Br J Pharmacol. 2022; 180(1):111-128.
PMID: 36098250
PMC: 10092446.
DOI: 10.1111/bph.15951.
Purinergic receptors are a key bottleneck in tumor metabolic reprogramming: The prime suspect in cancer therapeutic resistance.
Aria H, Rezaei M, Nazem S, Daraei A, Nikfar G, Mansoori B
Front Immunol. 2022; 13:947885.
PMID: 36072596
PMC: 9444135.
DOI: 10.3389/fimmu.2022.947885.
Physiologic roles of P2 receptors in leukocytes.
Alberto A, da Silva Ferreira N, Bonavita A, Nihei O, Farias F, Bisaggio R
J Leukoc Biol. 2022; 112(5):983-1012.
PMID: 35837975
PMC: 9796137.
DOI: 10.1002/JLB.2RU0421-226RR.
How Structural Biology Has Directly Impacted Our Understanding of P2X Receptor Function and Gating.
Mansoor S
Methods Mol Biol. 2022; 2510:1-29.
PMID: 35776317
DOI: 10.1007/978-1-0716-2384-8_1.
P2X7 receptor: the regulator of glioma tumor development and survival.
Matysniak D, Chumak V, Nowak N, Kukla A, Lehka L, Oslislok M
Purinergic Signal. 2021; 18(1):135-154.
PMID: 34964926
PMC: 8850512.
DOI: 10.1007/s11302-021-09834-2.
Pathophysiological role of calcium channels and transporters in the multiple myeloma.
Li T, Chen J, Zeng Z
Cell Commun Signal. 2021; 19(1):99.
PMID: 34579758
PMC: 8477534.
DOI: 10.1186/s12964-021-00781-4.
Antagonism of the ATP-gated P2X7 receptor: a potential therapeutic strategy for cancer.
Drill M, Jones N, Hunn M, OBrien T, Monif M
Purinergic Signal. 2021; 17(2):215-227.
PMID: 33728582
PMC: 8155177.
DOI: 10.1007/s11302-021-09776-9.
P2X7 Variants in Oncogenesis.
Pegoraro A, De Marchi E, Adinolfi E
Cells. 2021; 10(1).
PMID: 33477845
PMC: 7832898.
DOI: 10.3390/cells10010189.
Protein disulfide isomerase-mediated S-nitrosylation facilitates surface expression of P2X7 receptor following status epilepticus.
Lee D, Kim J
J Neuroinflammation. 2021; 18(1):14.
PMID: 33407649
PMC: 7788848.
DOI: 10.1186/s12974-020-02058-y.
Role of Conserved Residues and F322 in the Extracellular Vestibule of the Rat P2X7 Receptor in Its Expression, Function and Dye Uptake Ability.
Rupert M, Bhattacharya A, Stillerova V, Jindrichova M, Mokdad A, Boue-Grabot E
Int J Mol Sci. 2020; 21(22).
PMID: 33182845
PMC: 7696158.
DOI: 10.3390/ijms21228446.
P2X7 Receptor-Dependent microRNA Expression Profile in the Brain Following Status Epilepticus in Mice.
Conte G, Nguyen N, Alves M, de Diego-Garcia L, Kenny A, Nicke A
Front Mol Neurosci. 2020; 13:127.
PMID: 32982684
PMC: 7485385.
DOI: 10.3389/fnmol.2020.00127.
P2X7 Receptor at the Crossroads of T Cell Fate.
Rivas-Yanez E, Barrera-Avalos C, Parra-Tello B, Briceno P, Rosemblatt M, Saavedra-Almarza J
Int J Mol Sci. 2020; 21(14).
PMID: 32668623
PMC: 7404255.
DOI: 10.3390/ijms21144937.
Purinergic Signaling in the Hallmarks of Cancer.
Campos-Contreras A, Diaz-Munoz M, Vazquez-Cuevas F
Cells. 2020; 9(7).
PMID: 32635260
PMC: 7407645.
DOI: 10.3390/cells9071612.
P2 Receptors as Therapeutic Targets in the Salivary Gland: From Physiology to Dysfunction.
Khalafalla M, Woods L, Jasmer K, Munoz Forti K, Camden J, Jensen J
Front Pharmacol. 2020; 11:222.
PMID: 32231563
PMC: 7082426.
DOI: 10.3389/fphar.2020.00222.
Evolutionary Origin of the P2X7 C-ter Region: Capture of an Ancient Ballast Domain by a P2X4-Like Gene in Ancient Jawed Vertebrates.
Rump A, Smolander O, Ruutel Boudinot S, Kanellopoulos J, Boudinot P
Front Immunol. 2020; 11:113.
PMID: 32117264
PMC: 7016195.
DOI: 10.3389/fimmu.2020.00113.